Clinical Trial Update: Topical Calcipotriene Treatment for Breast Cancer Immunoprevention [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating topical calcipotriene for breast cancer immunoprevention has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Calcipotriene (calcipotriene)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED